首页> 外文OA文献 >PMS60 - CLINICAL AND ECONOMIC 'REAL WORLD” ANALYSIS OF THE SWITCHING FROM REMICADE (INFLIXIMABE) BY REMSIMA (INFLIXIMAB BIOSSIMILAR) OF PLANSERV PATIENTS WITH RHEUMATOID ARTHRITIS, ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS.

【2h】

PMS60 - CLINICAL AND ECONOMIC 'REAL WORLD” ANALYSIS OF THE SWITCHING FROM REMICADE (INFLIXIMABE) BY REMSIMA (INFLIXIMAB BIOSSIMILAR) OF PLANSERV PATIENTS WITH RHEUMATOID ARTHRITIS, ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS.

机译：PMS60 - 临床和经济“现实世界”分析Remsima（infliximabBiossimilar）的Remsima（incriximabbe）对类风湿性关节炎，强直性脊柱炎和银屑病关节炎的影响分析。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
R.R. Nascimento Junior;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. CLINICAL AND ECONOMIC IMPACT OF THE USE OF INFLIXIMAB BIOSIMILAR INFLECTRA IN RHEUMATOID ARTHRITIS, PSORIATIC ARTHROPATHY AND ANKYLOSING SPONDYLITIS PATIENTS [J] . Borras Blasco J., Gracia-Perez A., Castera D., Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2016,第7期

机译：在风湿性关节炎，银屑病性关节炎和强直性脊柱炎患者中使用英美昔布类真菌感染的临床和经济影响
2. Observational study of switching anti-TNF agents in ankylosing spondylitis and psoriatic arthritis versus rheumatoid arthritis. [J] . Haberhauer G, Strehblow C, Fasching P Wiener medizinische Wochenschrift . 2010,第9a10期

机译：在强直性脊柱炎和银屑病关节炎与类风湿关节炎中转换抗TNF药物的观察研究。
3. Infliximab Biosimilar use in Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Patients: The RHUMADATA Registry Experience [J] . Moura Cristiano, Choquette Denis, Coupal Louis, The Journal of rheumatology . 2019,第7期

机译：英夫利昔单抗在类风湿性关节炎，强直性脊柱炎和银屑病关节炎患者中使用：Rhumadata注册经验
4. No adverse physiological responses to infrared whole body hyperthermia in patients with rheumatoid arthritis and ankylosing spondylitis compared to healthy subjects. [C] . F.G.J. OOSTERVELD, E. KOOPMAN, J. OLDE SCHOLTENHUIS, Advances in biomedical research . 2010

机译：与健康受试者相比，类风湿性关节炎和强直性脊柱炎患者对红外全身热疗没有不利的生理反应。
5. Real-world evidence of the impact of adalimumab on work productivity and sleep measures in patients with rheumatoid arthritis psoriatic arthritis and ankylosing spondylitis [O] . Maria G. Tektonidou, Gkikas Katsifis, Athanasios Georgountzos, 2020

机译：真实世界的证据表明Adalimalab对类风湿性关节炎银屑病关节炎和强直性脊柱炎患者工作生产率和睡眠措施的影响
6. 4CPS-111 Clinical and economic impact of infliximab biosimilar Inflectra in rheumatoid arthritis, psoriatic arthropathy and ankylosing spondylitis naïve and switched patients: 5 years of follow-up [O] . J Borras, A Gracia-Pérez, A Valcuende Rosique, 2020

机译：4CPS-111英夫利昔单抗生物纤维腹泻中的临床和经济影响类风湿性关节炎，银屑病关节病和强直性脊柱炎Naïve和切换患者：5年后续行动

PMS60 - CLINICAL AND ECONOMIC 'REAL WORLD” ANALYSIS OF THE SWITCHING FROM REMICADE (INFLIXIMABE) BY REMSIMA (INFLIXIMAB BIOSSIMILAR) OF PLANSERV PATIENTS WITH RHEUMATOID ARTHRITIS, ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS.

著录项

相似文献

相关主题

期刊订阅